MORGAN BROWN: Open Payments
NPI 1194219105 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 38 payments from 13 companies in 2025. Trend: 2023 $779 · 2024 $580 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $194 |
| Novartis Pharmaceuticals Corporation | 8 | $166 |
| E.R. Squibb & Sons, L.L.C. | 3 | $154 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| ABIOMED | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $31 |
| Edwards Lifesciences Corporation | 1 | $28 |
Products named: ELIQUIS, LEQVIO, CAMZYOS, VYNDAQEL, Kerendia, ONPATTRO, VERQUVO, FARXIGA.
Industry payments across KY — which companies pay providers there.
